Dominique Lejeune

d groupe d’analyse, sri, montréal, qc, canadahttps://orcid.org/0000-0002-0981-0486view further author information

H指数:16

被引数:848

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The real-world impact of cariprazine on short- and long-term disability outcomes among commercially insured patients in the United States

卡利拉嗪对美国商业保险患者短期和长期残疾结局的实际影响

JOURNAL OF MEDICAL ECONOMICS

IF3

2025-02-190

Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data

ADVANCES IN THERAPY

IF4

2024-12-051

OAAI

Healthcare resource utilization and costs of chronic lymphocytic leukemia/small lymphocytic lymphoma patients who relapse or are refractory to ibrutinib

复发或伊布替尼难治的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的医疗资源利用和成本

FUTURE ONCOLOGY

IF2.6

2024-10-070

OAAI

Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery Disease

ADVANCES IN THERAPY

IF4

2023-03-063

OAAI

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population

ADVANCES IN THERAPY

IF4

2023-01-193

OAAI

Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population

ADVANCES IN THERAPY

IF4

2021-08-217

OAAI

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors

ADVANCES IN THERAPY

IF4

2021-07-1954

OAAI

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population

ADVANCES IN THERAPY

IF4

2021-07-1724

OAAI

Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)

美国 (US) 非瓣膜性房颤 (NVAF) 合并肥胖和多重用药患者利伐沙班和华法林的有效性和安全性比较

ADVANCES IN THERAPY

IF4

2021-05-255

OAAI

Real-world genetic testing patterns in metastatic castration-resistant prostate cancer

FUTURE ONCOLOGY

IF2.6

2021-04-2821

Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US

美国转移性去势抵抗性前列腺癌 (mCRPC) 患者 (pts) 的真实世界治疗 (Tx) 模式

ANNALS OF ONCOLOGY

IF65.4

2020-09-011

OAAI

Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)

ANNALS OF ONCOLOGY

IF65.4

2020-09-011

OAAI

Real-world treatment (Tx) patterns in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair mutations (HRRm plus )

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation

JOURNAL OF CARDIAC FAILURE

IF8.2

2019-06-0114

OAAI

REAL-WORLD ADHERENCE, COSTS, AND TREATMENT DOSAGE OF PATIENTS WITH NEUROENDOCRINE TUMORS (NET) TREATED WITH OCTREOTIDE OR LANREOTIDE

VALUE IN HEALTH

IF6

2019-05-010

OAAI

ECONOMIC BURDEN ASSOCIATED WITH SEVERE ADVERSE EVENTS IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER TREATED WITH FIRST-LINE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS

VALUE IN HEALTH

IF6

2019-05-010

OAAI

REAL-WORLD DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL)

VALUE IN HEALTH

IF6

2019-05-010

OAAI

The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2018-12-1810

OAAI

Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population

CHEST

IF8.6

2018-12-017

OAAI

An answer to anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2018-08-070

Dominique Lejeune

个人简介

教育背景

工作经历

荣誉奖项

研究方向